"Kidney Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancers of the KIDNEY.
Descriptor ID |
D007680
|
MeSH Number(s) |
C04.588.945.947.535 C12.758.820.750 C12.777.419.473 C13.351.937.820.535 C13.351.968.419.473
|
Concept/Terms |
Kidney Neoplasms- Kidney Neoplasms
- Kidney Neoplasm
- Neoplasm, Kidney
- Renal Neoplasms
- Neoplasm, Renal
- Neoplasms, Renal
- Renal Neoplasm
- Neoplasms, Kidney
Cancer of Kidney- Cancer of Kidney
- Kidney Cancers
- Renal Cancer
- Cancer, Renal
- Cancers, Renal
- Renal Cancers
- Cancer of the Kidney
- Kidney Cancer
- Cancer, Kidney
- Cancers, Kidney
|
Below are MeSH descriptors whose meaning is more general than "Kidney Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Kidney Neoplasms".
This graph shows the total number of publications written about "Kidney Neoplasms" by people in this website by year, and whether "Kidney Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 17 | 1 | 18 |
1995 | 16 | 1 | 17 |
1996 | 19 | 3 | 22 |
1997 | 21 | 3 | 24 |
1998 | 17 | 3 | 20 |
1999 | 19 | 2 | 21 |
2000 | 13 | 5 | 18 |
2001 | 19 | 5 | 24 |
2002 | 27 | 7 | 34 |
2003 | 35 | 6 | 41 |
2004 | 25 | 7 | 32 |
2005 | 33 | 5 | 38 |
2006 | 39 | 2 | 41 |
2007 | 52 | 5 | 57 |
2008 | 63 | 8 | 71 |
2009 | 56 | 7 | 63 |
2010 | 67 | 7 | 74 |
2011 | 67 | 3 | 70 |
2012 | 60 | 5 | 65 |
2013 | 59 | 5 | 64 |
2014 | 68 | 8 | 76 |
2015 | 74 | 1 | 75 |
2016 | 71 | 6 | 77 |
2017 | 73 | 2 | 75 |
2018 | 50 | 4 | 54 |
2019 | 48 | 2 | 50 |
2020 | 59 | 4 | 63 |
2021 | 59 | 4 | 63 |
2022 | 42 | 0 | 42 |
2023 | 63 | 2 | 65 |
2024 | 40 | 4 | 44 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kidney Neoplasms" by people in Profiles.
-
Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith-Wiedemann Syndrome and Other Predisposition Syndromes. Clin Cancer Res. 2024 Dec 02; 30(23):5260-5269.
-
Outcomes of relapsed favorable-histology Wilms tumor in non-clinical trial setting. Pediatr Blood Cancer. 2025 Jan; 72(1):e31347.
-
Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone. Cancer Res Commun. 2024 Oct 01; 4(10):2621-2637.
-
Vascular heterogeneity of tight junction Claudins guides organotropic metastasis. Nat Cancer. 2024 Sep; 5(9):1371-1389.
-
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma. J Clin Oncol. 2024 Nov 20; 42(33):3911-3916.
-
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer. Cancer Res Commun. 2024 Sep 01; 4(9):2444-2453.
-
Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity. Int Immunopharmacol. 2024 Dec 05; 142(Pt A):113004.
-
Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case series. RMD Open. 2024 08 30; 10(3).
-
Targeting multiple receptor tyrosine kinases with sitravatinib: A Phase 1b study in advanced renal cell carcinoma and castrate-resistant prostate cancer. Invest New Drugs. 2024 Oct; 42(5):547-558.
-
First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study. Eur Urol. 2024 Dec; 86(6):503-512.